Liquidia Corporation (LQDA)

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Liquidia Announces Poster Presentations at the PHA 2026 International PH Conference and Scientific Sessions

MORRISVILLE, N.C., June 11, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical...

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Liquidia Corporation Announces Inclusion in the S&P SmallCap 600® Index

MORRISVILLE, N.C., June 08, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (Nasdaq: LQDA), a biopharmaceutical...

Marvell Technology and Flex Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

Marvell Technology and Flex Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 PR Newswire NEW YORK, June 5...

Form 4 - Statement of changes in beneficial ownership of securities

Liquidia Corporation to Present at 2026 Jefferies Global Healthcare Conference

MORRISVILLE, N.C., May 27, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (Nasdaq: LQDA) today announced that...

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Liquidia (LQDA) Shares Rise After Strong Q1 Earnings and Revenue Beat

Liquidia Corporation (NASDAQ:LQDA) shares gained nearly 3% in premarket trading on Monday after the biopharmaceutical company reported...